Loading company…
Shenzhen Neoimmune develops technologies and products for immune disease detection and treatment.
Founded in 2019 and based in Shenzhen, China, Shenzhen Neoimmune develops technologies to read and analyze T and B lymphocyte receptor profiles for clinical testing and treatment. Its products include minimal residual disease testing, the FAIR-SEQ™ VJ multiple amplification library building kit and tumor immunotherapy solutions.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in